Medicare

Weight Loss Drugs & the Stock Market: Unraveling the Interplay of Pharmaceuticals, Food & Finance

The weight-loss effects of GLP-1 drugs are making big changes in many industries, but the impact on Wall Street is likely to be negligible. Here’s why.